Mizuho analyst Christopher Parkinson maintains Mosaic (NYSE:MOS) with a Buy and lowers the price target from $89 to $84.
Critical Insights From Tandem Diabetes Care Analyst Ratings: What You Need To Know
In the latest quarter, 15 analysts provided ratings for Tandem Diabetes Care (NASDAQ:TNDM), showcasing a mix of bullish…